Published 22:58 IST, July 15th 2020

The global race for COVID-19 cure: What is the progress on vaccines?

As the race for a COVID-19 vaccine gains pace, here is the progress of five countries- the United Kingdom, the United States, India, China and Russia.

Reported by: Sai Deepthi Pavani
Follow: Google News Icon
  • share
null | Image: self
Advertisement

As  race for a COVID-19 vaccine gains pace, here is progress of five countries: United Kingdom, United States, India, China and Russia: 

United Kingdom:

United Kingdom is carrying out highest number of  24.5% clinical trials. British pharmaceutical company AstraZeneca along with University of Oxford is developing AZD122 which is being ministered to 8,000 participants in Phase III trials. Starting a race for first claim on vaccine, AstraZeneca anunced deals with United States and European governments to supply 400 million doses of unproven vaccine each.  

Advertisement

Re: Asian Markets Mostly Higher On Hopes For Coronavirus Vaccine

China:

China is also in race to develop a vaccine. China’s Sivac’s trial of an inactivated vaccine in Brazil is one of two listed by World Health Organisation in clinical trial sts. 

Advertisement

Russia:

Russia's Sechev University claims it has successfully completed clinical trials of what it describes as world's first coronavirus vaccine. WHO said vaccine was still in Phase I trials and has to undergo two more levels of large-scale trials for it to be listed as safe for use.  

India: 

In India, Bharat Biotech International has received regulatory approval to start human clinical trials for its experimental shot of vaccine named Covaxin. aim is for it to be unveiled by August 15, after completion of all clinical trials.

Advertisement

Re: Tamil Nu: BCG Vaccine Trials ministered For ults Between 60-95 Group

United Forces: 

In United States, Trump ministration has financed development of 4 COVID-19 vaccines developed by Johnson & Johnson, Moderna Inc, AstraZeneca Plc and vovax Inc. under Operation Warp Speed Program which aims to produce 300 million vaccine doses by end of 2021. On Tuesday, Moderna Inc’s experimental vaccine anunced successful completion of Phase I trials. Earlier this month, vavax also received $1.6 billion from US government for delivering 100 million doses by late 2020. 

Advertisement

Re: More Than 150 Countries Sign Up For Global Vaccine Plan

Re: Russian Defence Ministry Declares Coronavirus Vaccine Safe; Volunteers Discharged

Advertisement

(Im credits: AP)

22:58 IST, July 15th 2020